Name: Dr John Davis
University of Oxford

Events this person is speaking at:

Tuesday 31 October 2017

New approaches to the crisis in finding therapies for neurodegenerative diseases underlying dementia
Date: 31 October 2017, 12:00 - 13:00
Speaker : Dr John Davis (University of Oxford)
Venue: Pharmacology, off Mansfield Road OX1 3QT
Venue Details: Lecture Theatre
Organiser: Carolyn Thackrah (University of Oxford, Department of Pharmacology)
Host: Associate Professor Grant Churchill (Department of Pharmacology, University of Oxford)

Events this person is hosting:

Tuesday 12 July 2016

Innate Immunity as potential therapeutic targets in Alzheimer's disease
Date: 12 July 2016, 13:00 - 14:30
Speaker : Dr. David Brough (University of Manchester)
Venue: NDM Building, Headington OX3 7FZ
Venue Details: Basement Seminar Room
Organiser: Andrea Keyte (University of Oxford, Target Discovery Institute)
Host: Dr John Davis (University of Oxford)

Tuesday 5 September 2017

Pharmacological modulation of CSF1R activation to control microglial proliferation in neurodegenerative disease
Date: 5 September 2017, 13:00 - 14:00
Speaker : Dr Emilie Simon (University of Southampton)
Venue: NDM Building, Headington OX3 7FZ
Venue Details: Basement Seminar Room
Organiser: Keeley Jones (University of Oxford)
Host: Dr John Davis (University of Oxford)

Thursday 9 May 2019

The role of the cadherin proteins in Alzheimer's disease
Date: 9 May 2019, 13:30 - 14:30
Speaker : Professor Cornelia van Duijn (University of Oxford)
Venue: NDM Building, Headington OX3 7FZ
Venue Details: Seminar room
Organiser: Kate Humphrey (University of Oxford)
Host: Dr John Davis (University of Oxford)

Events this person is organising:

Monday 18 September 2023

Translational Neuroscience Seminar
Date: 18 September 2023, 10:30 - 13:00
Speaker s: Professor Cornelia van Duijn (University of Oxford), Dr Roman Fischer (University of Oxford), Bjorn Vahsen (Postdoctoral Researcher and Fulford Junior Research Fellow, NDCN), Richard Hargreaves (Head of Neuroscience Research and Early Development at Bristol Myers Squibb)
Venue: Dorothy Crowfoot Hodgkin Building, off South Parks Road OX1 3QU
Venue Details: Biochemistry Building Phase 1 Ground Floor Main Seminar Room '20-026'
Organisers: Charlotte Bell (Business Partnerships Office), Professor Kevin Talbot (University of Oxford), Dr John Davis (University of Oxford)
Host: Professor Kevin Talbot (University of Oxford)